Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Integration of ER protein quality-control mechanisms defines β cell function and ER architecture
Neha Shrestha, … , Peter Arvan, Ling Qi
Neha Shrestha, … , Peter Arvan, Ling Qi
Published November 8, 2022
Citation Information: J Clin Invest. 2023;133(1):e163584. https://doi.org/10.1172/JCI163584.
View: Text | PDF
Research Article Cell biology Metabolism

Integration of ER protein quality-control mechanisms defines β cell function and ER architecture

  • Text
  • PDF
Abstract

Three principal ER quality-control mechanisms, namely, the unfolded protein response, ER-associated degradation (ERAD), and ER-phagy are each important for the maintenance of ER homeostasis, yet how they are integrated to regulate ER homeostasis and organellar architecture in vivo is largely unclear. Here we report intricate crosstalk among the 3 pathways, centered around the SEL1L-HRD1 protein complex of ERAD, in the regulation of organellar organization in β cells. SEL1L-HRD1 ERAD deficiency in β cells triggers activation of autophagy, at least in part, via IRE1α (an endogenous ERAD substrate). In the absence of functional SEL1L-HRD1 ERAD, proinsulin is retained in the ER as high molecular weight conformers, which are subsequently cleared via ER-phagy. A combined loss of both SEL1L and autophagy in β cells leads to diabetes in mice shortly after weaning, with premature death by approximately 11 weeks of age, associated with marked ER retention of proinsulin and β cell loss. Using focused ion beam scanning electron microscopy powered by deep-learning automated image segmentation and 3D reconstruction, our data demonstrate a profound organellar restructuring with a massive expansion of ER volume and network in β cells lacking both SEL1L and autophagy. These data reveal at an unprecedented detail the intimate crosstalk among the 3 ER quality-control mechanisms in the dynamic regulation of organellar architecture and β cell function.

Authors

Neha Shrestha, Mauricio Torres, Jason Zhang, You Lu, Leena Haataja, Rachel B. Reinert, Jeffrey Knupp, Yu-Jie Chen, Allen H. Hunter, Gunes Parlakgul, Ana Paula Arruda, Billy Tsai, Peter Arvan, Ling Qi

×

Figure 4

ERAD deficiency enhances ER-phagy of ER-retained proinsulin in β cells.

Options: View larger image (or click on image) Download as PowerPoint
ERAD deficiency enhances ER-phagy of ER-retained proinsulin in β cells.
...
(A) Representative TEM images showing autophagic vacuoles (AV), marked by red asterisk (right panel) in bafilomycin-treated (Baf, 100 nM for 2 hours) islets of WT and Sel1LIns1 mice. Quantitation of AVs per cell is shown on the right (n = 100–130 β cells from 2 mice for each genotype). Scale bars: 1 μm. (B) Zoomed TEM images showing ER-like structures (blue arrows) and mitochondria (green arrows) in AVs (white arrows). Boxed area shows magnified images highlighting the ER inside the AVs. Scale bars: 300 nm and 100 nm (zoomed images on right). (C) Immunogold labeling against BiP (diameter, 18 nm), AVs are marked by yellow circles and gold particles are color coded in the right panel. Quantitation of total BiP particles in each AV is shown on the right; n = 50–100 β cells from 2 mice for each genotype. (D) Immunogold labeling against BiP (diameter, 18 nm) and proinsulin (diameter, 12 nm); gold particles are color coded in the right panel. Quantitation of percentage of BiP+Proins+ AV per cell is shown on the right (n = 40–50 β cells from 2 mice for each genotype. Scale bars: 300 nm. ***P < 0.001, ****P < 0.0001 by unpaired, 2-tailed Student’s t test. (E) TEM of pancreatic islets from Atg7Ins1 and Sel1LIns1;Atg7Ins1 mice. Asterisks indicate aggregates; secretory granules (SG) are marked by blue arrows and ER by red arrows. Scale bars: 1 μm (left) and 200 nm (right). (F) Representative confocal images of KDEL and p62 staining in pancreatic islets from Atg7Ins1 and Sel1LIns1;Atg7Ins1 mice. Arrows indicate colocalization of KDEL and p62 signals. Scale bars: 50, 10, and 2 μm (left to right).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts